Tuttle KR - Search Results

1

Molecular mechanisms and therapeutic targets for diabetic kidney disease.

Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J. Tuttle KR, et al. Kidney Int. 2022 Aug;102(2):248-260. doi: 10.1016/j.kint.2022.05.012. Epub 2022 Jun 3. Kidney Int. 2022. PMID: 35661785 Free article. Review.

2

Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study.

Tuttle KR, Puhlman ME, Cooney SK, Short R. Tuttle KR, et al. Am J Kidney Dis. 1999 Nov;34(5):918-25. doi: 10.1016/S0272-6386(99)70051-X. Am J Kidney Dis. 1999. PMID: 10561150

3

A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.

Tuttle KR, Anderson PW. Tuttle KR, et al. Am J Kidney Dis. 2003 Sep;42(3):456-65. doi: 10.1016/s0272-6386(03)00741-8. Am J Kidney Dis. 2003. PMID: 12955673 Review.

4

Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C.

Tuttle KR, Johnson EC, Cooney SK, Anderberg RJ, Johnson EK, Clifton GD, Meek RL. Tuttle KR, et al. Kidney Int. 2005 Mar;67(3):953-68. doi: 10.1111/j.1523-1755.2005.00159.x. Kidney Int. 2005. PMID: 15698434 Free article.

5

The effect of ruboxistaurin on nephropathy in type 2 diabetes.

Tuttle KR, Bakris GL, Toto RD, McGill JB, Hu K, Anderson PW. Tuttle KR, et al. Diabetes Care. 2005 Nov;28(11):2686-90. doi: 10.2337/diacare.28.11.2686. Diabetes Care. 2005. PMID: 16249540 Clinical Trial.

6

Implications of chronic kidney disease for dietary treatment in cardiovascular disease.

Packard DP, Milton JE, Shuler LA, Short RA, Tuttle KR. Packard DP, et al. Among authors: tuttle kr. J Ren Nutr. 2006 Jul;16(3):259-68. doi: 10.1053/j.jrn.2006.04.022. J Ren Nutr. 2006. PMID: 16825032 Review.

7

Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.

Gilbert RE, Kim SA, Tuttle KR, Bakris GL, Toto RD, McGill JB, Haney DJ, Kelly DJ, Anderson PW. Gilbert RE, et al. Among authors: tuttle kr. Diabetes Care. 2007 Apr;30(4):995-6. doi: 10.2337/dc06-2079. Epub 2007 Jan 17. Diabetes Care. 2007. PMID: 17229944 Clinical Trial. No abstract available.

8

Advanced glycation end products and nephrotoxicity of high-protein diets.

Uribarri J, Tuttle KR. Uribarri J, et al. Among authors: tuttle kr. Clin J Am Soc Nephrol. 2006 Nov;1(6):1293-9. doi: 10.2215/CJN.01270406. Epub 2006 Sep 27. Clin J Am Soc Nephrol. 2006. PMID: 17699361 Review.

9

Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease.

Tuttle KR, McGill JB, Haney DJ, Lin TE, Anderson PW; PKC-DRS, PKC-DMES, and PKC-DRS 2 Study Groups. Tuttle KR, et al. Clin J Am Soc Nephrol. 2007 Jul;2(4):631-6. doi: 10.2215/CJN.00840207. Epub 2007 May 30. Clin J Am Soc Nephrol. 2007. PMID: 17699475 Clinical Trial.

10

Albuminuria reduction: the holy grail for kidney protection.

Tuttle KR. Tuttle KR. Kidney Int. 2007 Oct;72(7):785-6. doi: 10.1038/sj.ki.5002505. Kidney Int. 2007. PMID: 17882241 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters